First-Ever Double-Blind, Randomized Study Titled, “Effects of a CBD-containing Supercritical Fluid Extract of Hemp on Markers of Optimal Wellness, Stress Resilience, and.
CV Sciences Inc.
At CV Sciences, our mission to improve well‐being underscores our values, operations, and products.
Biotechnology
1d
5d
1m
6m
1y
Max
CV Sciences Inc. News
17 Jun
Groundbreaking Research Proves Efficacy of PlusCBD™ Oil in Sleep, Wellness and Weight-Loss Applications
13 Jun
CV Sciences, Inc. to Present at the Oppenheimer 19th Annual Consumer Conference
LAS VEGAS, June 13, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) a preeminent supplier and manufacturer of hemp CBD products.
12 Jun
CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.
12 Jun
CV Sciences, Inc. Announces New Distribution With Kroger and Expands Its Offering of Topical Products
PlusCBD™ Oil Roll-On Launch at 945 Kroger Stores in 17 U.S. States LAS VEGAS, June 12, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or.
Top hemp CBD Company urges FDA to swiftly develop regulations to separate an agricultural commodity from a controlled substance and ensure consumer safety LAS VEGAS, June 06,.
Illinois became the first state to approve approved recreational marijuana use for adults by legislature, as opposed to a voter referendum.
22 May
CV Sciences, Inc. Applauds California Assembly Support of Hemp-derived CBD products through Unanimous Passi
CV Sciences, Inc. (CVSI) (the “Company”, “”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products through its industry-dominating brand, PlusCBD Oil™, announces...
14 May
CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD
CV Sciences, Inc. (CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, is pleased to announced that its industry-dominating...
10 May
Edited Transcript of CVSI earnings conference call or presentation 8-May-19 8:30pm GMT
Q1 2019 CV Sciences Inc Earnings Call
Record quarterly revenue Increased retail distribution by over 1,000 stores LAS VEGAS, May 08, 2019 -- CV Sciences, Inc. (OTCQB:CVSI) ("CV Sciences" or the “Company”).
About CV Sciences Inc.
CV Sciences, Inc., a life sciences organization, is focused on promoting healthy living through their pharmaceutical drug development efforts and portfolio of finished product brands. CV Sciences’ Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications utilizing cannabidiol as the active pharmaceutical ingredient. CV Sciences’ Consumer Products Division delivers botanical‐based cannabidiol products
Participation in events
- Industrial Hemp Summit
- 150 Slayton Ave, Danville, VA 24540, USA
$ 0.04
8.28%
Open:
0.03
High:
0.04
Low:
0.03
Share volume:
657.921 K
Total value:
2.147 M
Market cap:
340.371 M
Symbol:
CVSI
Contact info
Phone:
(800) 561-8711
Address:
2688 S Rainbow Blvd, Las Vegas, NV 89146, USA
